Puig (Carolina Herrera, Rabanne, Charlotte Tilbury, Jean Paul Gaultier, Dries Van Noten, Nina Ricci, Byredo, Penhaligon’s, L’Artisan Parfumeur, Uriage, Apivita, Kama Ayurveda, Loto del Sur) has acquired a majority stake in German molecular cosmetics brand Dr. Barbara Sturm. Founder Dr. Barbara Sturm will retain a minority stake and continue leading the brand’s product development as Chief Product Development Officer and Brand Ambassador.
With this acquisition, Puig reinforces their competitive position in the premium skincare segment. Dr. Barbara Sturm is a globally recognized luxury cult brand developed through its digital channels and worldwide spa and boutiques network across Düsseldorf, London, New York, Miami, Los Angeles, Dallas, Jakarta, and Singapore, offering high-performance treatments with deep expertise in skincare.
“The new partnership reinforces Puig skincare segment and our presence in the U.S,” said Marc Puig, Chairman and CEO of Puig.
Launched in 2014, the Dr. Barbara Sturm Molecular Cosmetics brand now offers more than 300 products and more than 5,000 carefully curated skincare routines that have gained global recognition and a cult following.
All Dr. Barbara Sturm products are free of synthetic fragrances and parabens, and are cruelty-free and suitable for all skin types and concerns.
